Vilon

Vilon is an immune- and thymic-support bioregulatory peptide discussed for short repeating cycles, with the source using a distinctive 5-days-on, multi-week-off structure.

Profile · 01

Overview

Vilon is a short peptide bioregulator discussed for immune regulation, thymic function, and healthy-aging support. It is grouped with other Khavinson-style peptides rather than with classic immunotherapy agents.

The source protocol is distinctive because it uses short 5-day active cycles separated by longer off periods. This page preserves that structure instead of flattening it into a generic daily program.

At a Glance

Goal

Support immune regulation, thymic signaling, and healthy-aging research through cyclical short-course use

Protocol

Short 5-day cycles with dose escalation in Cycle 1 and higher active-day dosing in later cycles.

Reconstitute

Add 3.0 mL bacteriostatic water to a 20 mg vial for about 6.67 mg/mL concentration

Typical daily range

67-667 mcg on active days only

Start

67 mcg on Day 1 of Cycle 1, increasing daily to 333 mcg by Day 5

Target

333-667 mcg daily on Days 1-5 in Cycles 2 and beyond

Frequency

Once daily for 5 consecutive days per cycle (subcutaneous)

Cycle Length

5 days on, about 23 days off; repeat for 2-4 cycles over 8-16 weeks

Timing

Any consistent time; rotate injection sites during active days

Route

Subcutaneous

Cycle

5 days on, about 23 days off, repeated for 2-4 cycles

Use short daily active phases followed by longer off periods. This is a cyclical protocol by design, and the source treats the spacing between cycles as part of the intervention rather than as downtime that can be ignored.

Dose progression

Cycle 1 Day 1

67 mcg (0.067 mg) · 1 unit (0.01 mL)

Cycle 1 Day 2

133 mcg (0.133 mg) · 2 units (0.02 mL)

Cycle 1 Day 3

200 mcg (0.20 mg) · 3 units (0.03 mL)

Cycle 1 Day 4

267 mcg (0.267 mg) · 4 units (0.04 mL)

Cycle 1 Day 5

333 mcg (0.33 mg) · 5 units (0.05 mL)

Cycles 2+

333-667 mcg on Days 1-5 · 5-10 units (0.05-0.10 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Vilon works.

Vilon is discussed as a thymic and immune-regulation bioregulator meant to support healthy-aging and immune-balance signaling. The source emphasizes cyclical use rather than a continuous daily exposure pattern.

As with similar short bioregulator peptides, the evidence base is exploratory and should not be mistaken for standard immunology or infectious-disease management.

Science · 02

Effects

Observations from clinical or preclinical literature.

May support immune-regulation and thymic-support research goals

Short active cycles can make it easier to structure observation periods

Very small dose volumes keep injections brief

Human efficacy data remain limited

Mild injection-site irritation may occur

Science · 03

Caution

Not recommended during pregnancy or breastfeeding because safety data is insufficient

Use caution in significant immune disorders without qualified medical oversight

Do not treat this as a replacement for indicated medical evaluation, vaccination, or infection care

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Sleep hygiene

A foundational immune-support factor that should not be ignored.

Protein intake

Supports broader immune and recovery resilience.

Vitamin D

Relevant to immune-regulation context.

Stress management

Chronic stress can undercut immune-balance goals.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Use the off-cycle periods intentionally and track how symptoms or resilience shift across cycles

Prioritize sleep, stress reduction, nutrition, and infection-risk basics

Avoid equating immune-support language with treatment of active illness

Use consistent records because the cycle structure matters to interpretation

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

General illness resilience and recovery - only as broad context markers
Energy and well-being across cycles - useful observational context
Injection-site reactions - note redness, swelling, or discomfort

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CBC with differential

Useful general immune-context marker.

CMP (Comprehensive Metabolic Panel)

Assesses liver and kidney function during the protocol.

Vitamin D

Useful immune-support baseline context.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length

Vial size

Bac. water

Syringe

Vials

0 × 20 mg each…

Syringes

Bac. water

0 mL

Swabs

02 per syringe

Calculators · 02

Dose Calculator

Vial

Bac. water

Syringe

Dose

Concentration

0mcg/mL

Volume per dose

0mL

…

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

Allow vial to reach room temperature for 15–20 minutes before reconstitution.
Draw the chosen bacteriostatic water volume with a sterile syringe.
Inject slowly down vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully

Use a smaller-capacity insulin syringe when possible because the active-day doses are small

Pinch a skinfold and inject subcutaneously at 45-90 degrees

Rotate sites across active days and discard used syringes safely

Do not aspirate for subcutaneous injections

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized

Store at room temp in dry, dark conditions; minimize moisture exposure.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile syringe for each injection and dispose of it safely

This page uses an intentional cycle structure with off weeks, not a continuous daily protocol

Document cycle number, active-day dose, and off-cycle observations carefully for consistency

PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

Short-peptide bioregulator literature
Background literature relevant to thymic and immune-support bioregulator peptides.
https://pubmed.ncbi.nlm.nih.gov/25482216/
CDC
Subcutaneous injection route guidance.
https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf